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Abstract
Background: The human cancer-related nucleoside triphosphatase (HCR-NTPase) is
overexpressed in several tumour tissues including neuroblastoma. HCR-NTPase is an enzyme
exhibiting a slow in vitro activity in hydrolysing nucleosidetriphosphates. However, its in vivo
function is still unknown. To learn more about the physiological role of HCR-NTPase, we both
overexpressed and silenced it in the neuroblastoma cell line SH-SY5Y.
Findings: No effect was observed when the expression of endogenously expressed HCR-NTPase
in the cells was silenced by RNA interference. On the other hand, overexpression of HCR-NTPase
led to cytotoxicity of the protein in SH-SY5Y cells. Even if the catalytic essential amino acid
glutamate 114 was replaced by alanine (E114A-HCR-NTPase), the protein remained cytotoxic. The
results could be confirmed by successfully rescuing the cells via RNA interference.
Conclusion: Although expressed in several tumours, at least in SH-SY5Y, HCR-NTPase is not
essential for the cells to survive. Increased levels of the protein lead to cytotoxicity due to physical
intracellular interactions rather than hydrolysis of nucleosidetriphosphates by its intrinsic residual
enzymatic activity.
Reseach hypothesis
A screen of the cancer genome anatomy project (CGAP)
database [1,2] for expressed sequence tags that compared
to normal tissue are highly expressed in human tumours
revealed the human cancer-related nucleoside triphos-
phatase (HCR-NTPase) [3]. HCR-NTPase, the gene prod-
uct of the mRNA NM_032324 (synonyms: MGC13186,
LOC84284, C1orf57, GI:14150100) is described to
exhibit an increased expression profile in liver cholangi-
ocarcinoma when compared to normal tissue [3]. In addi-
tion, as retrieved from SOURCE [4,5] when this project
was initiated, HCR-NTPase was stated to be expressed in
many human tumours, several of them located in the
brain such as medullablastoma, glioblastoma, and neu-
roblastoma.
A homology search using BLAST [6,7] retrieved significant
sequence homologies between HCR-NTPase and proteins
assigned to COG1618 of the COG database [8]. As a rep-
resentative of COG1618 proteins, aaTHEP1 from the
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chemically characterised [9] and its crystal structure was
resolved [10]. Both HCR-NTPase and aaTHEP1 hydrolyse
ATP and GTP in vitro with Km in the micromolar range and
kcat in the range between 5 and 9 × 10-3 s-1 corresponding
to approximately 20–30 molecules hydrolysed per hour
and enzyme molecule. In addition, the proteins resemble
each other in terms of structure. They belong to the class
of P-loop NTPases, and their regular secondary structures
can be superimposed with a backbone RMSD of 2.8 Å [3].
Thus, aaTHEP1 and consequently COG1618 proteins
may serve as model systems for HCR-NTPase.
Analysing the phylogenetic distribution of COG1618 pro-
teins by phylogenetic COG ranking [11,12] reveals that
they are absent from almost all mesophiles and present in
all thermophiles, most of them archeae. In addition,
HCR-ATPase is present in many eucarya analysed thus far.
Therefore, HCR-ATPase and COG1618 proteins are at
least very similar to PACE proteins i. e. proteins from
archaea without assigned function that are conserved in
eukarya as described by Matte-Tailliez et al. [13]. The
authors argue that most of the PACE proteins are informa-
tional proteins and could be of strong biomedical interest.
The aim of this study was to obtain further insight into the
role of HCR-NTPase in tumour cells. For that purpose we
investigated the phenotype of the neuroblastoma cell line
SH-SY5Y [14] as a model system for brain tumours under
both conditions overexpressing and silencing HCR-
NTPase.
Methods
Eucaryotic cell culture and transfections
SH-SY5Y neuroblastoma cells [14] were obtained from
ATCC, Manassas, USA and grown at 37°C and 5% CO2 in
Dulbecco's modified Eagle's Medium containing 1% pen-
icillin/streptomycin and 15% fetal calf serum (growth
medium; GIBCO, Eggenstein, Germany) in a humidified
incubator. To keep the cells in logarithmic growth, conflu-
ent cells were washed with phosphate buffered saline
(PBS), detached by 0.05% Trypsin and 0.5 mM EDTA in
PBS, followed by washing and diluting them in fresh
growth medium. 106 cells were transfected with 2 μg Plas-
mid by electroporation in 50 μl of Cell Line Nucleofector
V solution (Amaxa, Cologne, Germany). After transfec-
tion, cells were washed in growth medium, transferred to
6-well plates and judged microscopically after 24 h of
incubation at 37°C and 5% CO2 using an Axiovert100
microscope (Zeiss, Oberkochen, Germany). Red fluores-
cent cells were analysed at 584 nm and green fluorescent
cells at 482 nm excitation. Three different fields of view
were evaluated for each experiment and all experiments
were performed independently in triplicate.
Silencing HCR-NTPase in SH-SY5Y by RNA interference
The expression of HCR-NTPase in SH-SY5Y cells was
blocked via RNA interference [15] using pSilencer1.0-U6
(Ambion, Darmstadt, Germany). shRNA coding inserts
flanked by ApaI and EcoRI restriction sites were con-
structed by phosphorylating 25 pmol of oligonucleotides
(Operon, Cologne, Germany) using T4 poynucleotide
kinase, followed by assembling complementary pairs by
incubation for 5 min at 100°C and 60 min at 37°C.
pSilencer1.0-U6 sequentially was cut by ApaI (Fermentas,
St. Leon-Rot, Germany) and EcoRI (Fermentas, St. Leon-
Rot, Germany), the inserts were inserted and the plasmids
were amplified in E. coli SURE (Stratagene, San Diego,
USA). Expression of HCR-NTPase was blocked by trans-
fecting SH-SY5Y cells with purified plasmids. The follow-
ing pairs of oligonucleotides were used:
siRNA1:
5'-ATC CAT AAA GCC AGT GAT TCT CAA GAG AAA TCA
CTG GCT TTA TGG ATC ATT TTT T-3' and
5'-AAT TAA AAA ATG ATC CAT AAA GCC AGT GAT TTC
TCT TGA GAA TCA CTG GCT TTA TGG ATG GCC-3'
siRNA2:
5'-AGA GCC TCC ACC TGG AAT TCT CAA GAG AAA TTC
CAG GTG GAG GCT CTA ATT TTT T-3' and
5'-AAT TAA AAA ATT AGA GCC TCC ACC TGG AAT TTC
TCT TGA GAA TTC CAG GTG GAG GCT CTG GCC-3'
siRNA3:
5'-GAA TGC CGA CTG CAG CAT TCT CAA GAG AAA TGC
TGC AGT CGG CAT TCC TTT TTT T-3' and
5'-AAT TAA AAA AAG GAA TGC CGA CTG CAG CAT TTC
TCT TGA GAA TGC TGC AGT CGG CAT TCG GCC-3'
siRNA4:
5'-TTC CTA AAG GAA AGC CAT TCT CAA GAG AAA TGG
CTT TCC TTT AGG AAC TTT TTT T-3' and
5'-AAT TAA AAA AAG TTC CTA AAG GAA AGC CAT TTC
TCT TGA GAA TGG CTT TCC TTT AGG AAG GCC-3'
Overexpressing HCR-NTPase in SH-SY5Y cells
HCR-NTPase cDNA was obtained from RZPD, Berlin, Ger-
many. The gene was amplified and cloned into pET101/
D-TOPO yielding pET101/D-TOPO/HCR-NTPase to
express the protein in E. coli. This construct also served as
the basis for all further cloning steps. HCR-NTPase wasPage 2 of 8
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Karlsruhe, Germany). The gene was amplified from
pET101/D-TOPO/HCR-NTPase using the primers
5'-AAA AGC TTA TGG CCC GGC ACG TGT TCC-3' and
5'-AAA ATC TAG ATC ACT TCC TGC TGC TCT G-3'.
The PCR-fragment was digested sequentially by XbaI (Fer-
mentas, St. Leon-Rot, Germany) and HindIII (Fermentas,
St. Leon-Rot, Germany), inserted into pRc/CMV and
amplified in E. coli TOP10 (Invitrogen, Karlsruhe, Ger-
many).
HCR-NTPase as a fusion with red fluorescent protein [16]
(HCR-NTPase-RFP) was overexpressed using the plasmid
pmaxFP-Red-C (Amaxa, Cologne, Germany). The gene
was amplified from pET101/D-TOPO/HCR-NTPase using
the primers
5'-AAA AGA TCT GGA GGA GGA GGA ATG GCC CGG
CAC GTG TTC-3' and
5'-AAG GTA CCT CAC TTC CTG CTG CTC TG-3'.
Before digesting with BglII (Fermentas, St. Leon-Rot, Ger-
many) and KpnI (Fermentas, St. Leon-Rot, Germany), the
PCR-fragment was inserted into pCR2.1-TOPO (Invitro-
gen, Karlsruhe, Germany). The resulting fragment was
inserted into pmaxFP-Red-C and amplified in E. coli
TOP10. As a control for the efficiency of transfection,
pmaxGFP (QIAGEN) was used. HCR-NTPase was overex-
pressed by transfecting SH-SY5Y cells with purified plas-
mids.
Construction of a E114A-HCR-NTPase mutant in pRc/
CMV
An enzymatically inactive HCR-NTPase mutant was con-
structed by mutating a conserved catalytic glutamate [17].
For that purpose, E114 of HCR-NTPase in pRc/CMV was
replaced by an alanin using the Phusion™ Site-Directed
Mutagenesis Kit (Finnzymes, Espoo, Finland) according
to the instructions of the manufacturer. The utilised phos-
phorylated primers were
5'-P-CGT CAT CGA TGC GAT TGG GAA GA-3' and
5'-P-CAC ACT CTT TGC CCT GGG CCA-3'.
Inhibition of apoptosis
Apoptosis was inhibited by adding the caspase inhibitor
Z-VAD-FMK (Promega, Mannheim) to the culture
medium directly after transfection at a final concentration
of 20 μM.
Bioinformatics
ClustalW-alignments were performed as previously
described [18,19] and for the graphical representation,
Genedoc was used [20].
All investigations have been performed in accordance to
German regulatory affairs.
Results
Loss-of-function: silencing HCR-NTPase by RNA 
interference
Since HCR-NTPase is overexpressed in neuroblastoma we
were interested in the phenotype of SH-SY5Y if the intrin-
sic expression of HCR-NTPase was suppressed. For that
purpose we constructed plasmids containing siRNAs
directed to the regions within HCR-NTPase that are
shown in figure 1. Untreated cells and those transfected
with plasmids containing siRNAs were analysed by their
cell counts as judged via phase contrast microscopy. To
show the effect caused by the transfection procedure, cells
transfected with constructs encoding GFP and RFP were
included as controls. As can be seen in figure 2, the cell
counts are reduced by about one fourth by the transfec-
tion procedure alone. However, compared to the GFP-
and RFP-controls the cells remain mainly unaffected
regardless of which siRNA constructs were introduced.
Gain-of-function: overexpressing HCR-NTPase in SH-
SY5Y
To judge the effect of overexpressed HCR-NTPase in SH-
SY5Y cells, transfections with different expression plas-
mids were performed. The cultures were then analysed by
both phase contrast and fluorescence microscopy. Com-
pared to the controls, HCR-NTPase, a combination of
HCR-NTPase and GFP as well as a fusion product between
HCR-NTPase and RFP (HCR-NTPase-RFP) gave rise to sig-
nificant fewer cell counts demonstrating HCR-NTPase
mediated cytotoxicity (Figure 3). Table 1 quantitatively
shows the cytotoxic action of HCR-NTPase. The efficiency
of transfection was judged by quantifying fluorescent cells
after being transfected with GFP and RFP containing plas-
mids. Compared to the total number of cells visible by
phase contrast microscopy, those also showing fluores-
cence were 80% and 64% for GFP and RFP, respectively.
As can be seen, far less than half of the cells survived if
transfected with either HCR-NTPase or HCR-NTPase-RFP.
Moreover, the fraction of red fluorescent cells after trans-
fection with HCR-NTPase-RFP was negligible, indicating
that the vast majority of surviving cells were untransfected
rather than unaffected by a successful transfection. Similar
results were obtained when the cells were cotransfected
with HCR-NTPase and GFP supporting the presumption
that the surviving cells contained no plasmids.Page 3 of 8
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To confirm that the expression of HCR-NTPase was
indeed the cause of the observed cell death after transfec-
tion with HCR-NTPase containing plasmids, we tried to
rescue the cells by means of RNA interference. Whereas
siRNA1 and siRNA4 showed no effect, siRNA2 signifi-
cantly increased the survival rate and siRNA3 was even
able to completely rescue the cells yielding the same cell
counts observed when the cells were transfected with plas-
mids encoding solely RFP or GFP (figure 4).
The E114A-HCR-NTPase mutant
HCR-NTPase belongs to the ASCE (additional strand, cat-
alytic E) class of NTPases [3]. In ASCE NTPases, NTP-
hydrolysis typically depends on a conserved catalytic
glutamate (E114 in HCR-NTPase and E107 in aaTHEP1).
This essential glutamate is described to prime a water mol-
ecule for a nucleophilic attack on the γ-phosphate [17,21].
Consequently, a mutant protein lacking this essential
glutamate is expected to be catalytically inactive. Such a
mutant was then suitable to decide whether unspecific
intracellular hydrolysis of nucleotides or the physical
interaction with other intracellular compounds is respon-
sible for the observed cytotoxicity. Hence, we constructed
the E114A-HCR-NTPase mutant and expressed it in SH-
SY5Y cells. As shown in figure 5, the effect of E114A-HCR-
NTPase on SH-SY5Y cells resembles that one observed
with the wild type protein. Although to a slightly lesser
degree, the cells are killed by E114A-HCR-NTPase and can
be rescued by siRNA3 mediated RNA interference exclud-
ing unspecific NTP-hydrolysis as the cause of cytotoxicity.
The cells died due to apoptosis as could be seen morpho-
logically. In addition, as judged by green fluorescence, we
successfully rescued them by the caspase inhibitor Z-VAD-
FMK (table 2).
Positions of siRNAs used to silence HCR-NTPase in SH-SY5YFigure 1
Positions of siRNAs used to silence HCR-NTPase in SH-SY5Y. ClustalW-alignment of the eight most diverse 
sequences out of a group of 29 species that have been found to contain Walker A and B motifs similar to those of HCR-
NTPase [3]. The sequences were from Homo sapiens, Mus musculus, Drosophila melanogaster, Aquifex aeolicus (aaTHEP1), Ther-
mophilum pendens, Methanopyrus kandleri, an uncultured archaeon, Sulfolobus tokodaii, and Aeropyrum pernix, respectively.
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Silencing HCR-NTPase in SH-SY5Y has no effectFigure 2
Silencing HCR-NTPase in SH-SY5Y has no effect. Normalised cell counts (in % of untransfected control) of SH-SY5Y 
transfected with plasmids containing GFP, RFP, siRNA1, siRNA2, siRNA3, and siRNA4, respectively. The data for the GFP- and 
RFP-controls are the same as those shown in table 1. The error bars indicate the standard deviations of at least 3 independ-
ently performed experiments.
0
10
20
30
40
50
60
70
80
90
100
co
nt
ro
l
GF
P
RF
P
siR
NA
1
siR
NA
2
siR
NA
3
siR
NA
4
%
 
o
f v
ita
l c
el
ls
Table 1: Quantitative analysis of the cytotoxicity of HCR-NTPase expressed in SH-SY5Y
Total red green
Control 100 - -
GFP6 76 (2) - 61 (2)
RFP6 67 (10) 43 (8) -
HCR-NTPase9 31 (5) - -
HCR-NTPase-RFP3 24 (3) 1 (1) -
GFP + HCR-NTPase6 30 (9) - 7 (2)
GFP + HCR-NTPase-RFP3 30 (4) 1 (1) 6 (2)
SH-SY5Y cells were transfected with plasmids containing green fluorescent protein (GFP), red fluorescent protein (RFP), HCR-NTPase, or a fusion 
of HCR-NTPase with red fluorescent protein (HCR-NTPase-RFP) as inserts. The percentage of total cells normalised to 100 for untreated cells 
(control) as microscopically judged by phase contrast (total), red fluorescence (red), and green fluorescence (green) are given. In parenthesis the 
standard deviations, and as uppercase numbers the number of independently performed experiments are stated.
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Cytotoxicity of HCR-NTPase expressed in SH-SY5YFigure 3
Cytotoxicity of HCR-NTPase expressed in SH-SY5Y. Phase contrast and fluorescence images of SH-SY5Y cells are 
shown. The cells were either untreated (A) or transfected with Plasmids encoding HCR-NTPase (B), GFP (C), GFP + HCR-
NTPase (D), RFP (E), and an HCR-NTPase-RFP fusion product (F).
A C E
B D F
Rescue of SH-SY5Y cells by RNA-interferenceFigur  4
Rescue of SH-SY5Y cells by RNA-interference. Normalised cell counts (in % of untransfected control) of SH-SY5Y 
transfected with plasmids encoding a fusion protein between HCR-NTPase and RFP alone (HCR-NTPase-RFP) or cotrans-
fected with siRNA1, siRNA2, siRNA3, and siRNA4, respectively. Compared to the control, less than 1% of cells containing the 
HCR-NTPase-RFP fusion protein could be detected by fluorescence microscopy (data not shown). The data for the GFP-, RFP- 
and HCR-NTPase-RFP-controls are the same as those shown in table 1. The error bars indicate the standard deviations of at 
least 3 independently performed experiments.
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Cytotoxicity of the E114A-HCR-NTPase mutant and rescue of SH-SY5Y cells by siRNA3Figure 5
Cytotoxicity of the E114A-HCR-NTPase mutant and rescue of SH-SY5Y cells by siRNA3. Normalised cell counts 
(in % of untransfected control) of SH-SY5Y transfected with plasmids encoding the E114A-HCR-NTPase mutant (E114A) alone 
or cotransfected with either GFP or siRNA3. Whereas fGFP + E114A were analysed by fluorescence microscopy, all other 
cells were counted via phase contrast microscopy. The data for the GFP-, RFP- and HCR-NTPase-controls are the same as 
those shown in table 1. The error bars indicate the standard deviations of at least 3 independently performed experiments.
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Table 2: Effect of Z-VAD-FMK on the cytotoxicity induced by HCR-NTPase and E114A-HCR-NTPase in SH-SY5Y
Treatment Fluorescent cells
GFP (control) 100 (20)
GFP + Z-VAD-FMK 93 (15)
GFP + HCR-NTPase 4 (4)
GFP + HCR-NTPase + Z-VAD-FMK 91 (21)
GFP + E114A-HCR-NTPase 79 (12)
GFP + E114A-HCR-NTPase + Z-VAD-FMK 95 (17)
SH-SY5Y cells were transfected with plasmids containing green fluorescent protein (GFP), HCR-NTPase or E114A-HCR-NTPase. The percentage of 
total cells normalised to 100 for cells only treated with GFP (control) as microscopically judged by green fluorescence are given with and without 
adding the caspase inhibitor Z-VAD-FMK. In parenthesis the standard deviations are stated. Three experiments were performed independently.
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